 | • レポートコード：MRC308GR11116 • 出版社/出版日：GlobalInfoResearch / 2023年8月14日 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のウィルソン病用診断の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のウィルソン病用診断市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– ウィルソン病用診断の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
ウィルソン病用診断市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・ペニシラミン、トリエンチン、テトラチオモリブデン酸
用途別セグメント
・病院薬局、オンライン薬局、小売薬局
主要な市場プレーヤー
・Orphalan、AstraZeneca、Vivet Therapeutics、Pfizer、Ultragenyx Pharmaceutical、Valeant Pharmaceuticals International, Inc.、Noblepharma Co., Ltd.、Merck & Co., Inc.、Teva Pharmaceuticals、Wilson Therapeutics AB
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、ウィルソン病用診断製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なウィルソン病用診断メーカーの企業概要、2019年～2022年までのウィルソン病用診断の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なウィルソン病用診断メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ウィルソン病用診断の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのウィルソン病用診断の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのウィルソン病用診断市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびウィルソン病用診断の産業チェーンを掲載しています。
・第14、15章では、ウィルソン病用診断の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– ウィルソン病用診断の概要
– 種類別分析（2018年vs2022年vs2029年）：ペニシラミン、トリエンチン、テトラチオモリブデン酸
– 用途別分析（2018年vs2022年vs2029年）：病院薬局、オンライン薬局、小売薬局
– 世界のウィルソン病用診断市場規模・予測
– 世界のウィルソン病用診断生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Orphalan、AstraZeneca、Vivet Therapeutics、Pfizer、Ultragenyx Pharmaceutical、Valeant Pharmaceuticals International, Inc.、Noblepharma Co., Ltd.、Merck & Co., Inc.、Teva Pharmaceuticals、Wilson Therapeutics AB
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：ペニシラミン、トリエンチン、テトラチオモリブデン酸
・用途別分析2018年-2029年：病院薬局、オンライン薬局、小売薬局
・ウィルソン病用診断の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ウィルソン病用診断のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ウィルソン病用診断のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ウィルソン病用診断の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ウィルソン病用診断の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Wilson’s Disease Diagnostic
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Wilson’s Disease Diagnostic Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Penicillamine
1.3.3 Trientine
1.3.4 Tetrathiomolybdate
1.4 Market Analysis by Application
1.4.1 Overview: Global Wilson’s Disease Diagnostic Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Online Pharmacies
1.4.4 Retail Pharmacies
1.5 Global Wilson’s Disease Diagnostic Market Size & Forecast
1.5.1 Global Wilson’s Disease Diagnostic Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Wilson’s Disease Diagnostic Sales Quantity (2018-2029)
1.5.3 Global Wilson’s Disease Diagnostic Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Orphalan
2.1.1 Orphalan Details
2.1.2 Orphalan Major Business
2.1.3 Orphalan Wilson’s Disease Diagnostic Product and Services
2.1.4 Orphalan Wilson’s Disease Diagnostic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Orphalan Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Wilson’s Disease Diagnostic Product and Services
2.2.4 AstraZeneca Wilson’s Disease Diagnostic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Vivet Therapeutics
2.3.1 Vivet Therapeutics Details
2.3.2 Vivet Therapeutics Major Business
2.3.3 Vivet Therapeutics Wilson’s Disease Diagnostic Product and Services
2.3.4 Vivet Therapeutics Wilson’s Disease Diagnostic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Vivet Therapeutics Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Wilson’s Disease Diagnostic Product and Services
2.4.4 Pfizer Wilson’s Disease Diagnostic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Ultragenyx Pharmaceutical
2.5.1 Ultragenyx Pharmaceutical Details
2.5.2 Ultragenyx Pharmaceutical Major Business
2.5.3 Ultragenyx Pharmaceutical Wilson’s Disease Diagnostic Product and Services
2.5.4 Ultragenyx Pharmaceutical Wilson’s Disease Diagnostic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ultragenyx Pharmaceutical Recent Developments/Updates
2.6 Valeant Pharmaceuticals International, Inc.
2.6.1 Valeant Pharmaceuticals International, Inc. Details
2.6.2 Valeant Pharmaceuticals International, Inc. Major Business
2.6.3 Valeant Pharmaceuticals International, Inc. Wilson’s Disease Diagnostic Product and Services
2.6.4 Valeant Pharmaceuticals International, Inc. Wilson’s Disease Diagnostic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Valeant Pharmaceuticals International, Inc. Recent Developments/Updates
2.7 Noblepharma Co., Ltd.
2.7.1 Noblepharma Co., Ltd. Details
2.7.2 Noblepharma Co., Ltd. Major Business
2.7.3 Noblepharma Co., Ltd. Wilson’s Disease Diagnostic Product and Services
2.7.4 Noblepharma Co., Ltd. Wilson’s Disease Diagnostic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Noblepharma Co., Ltd. Recent Developments/Updates
2.8 Merck & Co., Inc.
2.8.1 Merck & Co., Inc. Details
2.8.2 Merck & Co., Inc. Major Business
2.8.3 Merck & Co., Inc. Wilson’s Disease Diagnostic Product and Services
2.8.4 Merck & Co., Inc. Wilson’s Disease Diagnostic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck & Co., Inc. Recent Developments/Updates
2.9 Teva Pharmaceuticals
2.9.1 Teva Pharmaceuticals Details
2.9.2 Teva Pharmaceuticals Major Business
2.9.3 Teva Pharmaceuticals Wilson’s Disease Diagnostic Product and Services
2.9.4 Teva Pharmaceuticals Wilson’s Disease Diagnostic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Teva Pharmaceuticals Recent Developments/Updates
2.10 Wilson Therapeutics AB
2.10.1 Wilson Therapeutics AB Details
2.10.2 Wilson Therapeutics AB Major Business
2.10.3 Wilson Therapeutics AB Wilson’s Disease Diagnostic Product and Services
2.10.4 Wilson Therapeutics AB Wilson’s Disease Diagnostic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wilson Therapeutics AB Recent Developments/Updates
3 Competitive Environment: Wilson’s Disease Diagnostic by Manufacturer
3.1 Global Wilson’s Disease Diagnostic Sales Quantity by Manufacturer (2018-2023)
3.2 Global Wilson’s Disease Diagnostic Revenue by Manufacturer (2018-2023)
3.3 Global Wilson’s Disease Diagnostic Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Wilson’s Disease Diagnostic by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Wilson’s Disease Diagnostic Manufacturer Market Share in 2022
3.4.2 Top 6 Wilson’s Disease Diagnostic Manufacturer Market Share in 2022
3.5 Wilson’s Disease Diagnostic Market: Overall Company Footprint Analysis
3.5.1 Wilson’s Disease Diagnostic Market: Region Footprint
3.5.2 Wilson’s Disease Diagnostic Market: Company Product Type Footprint
3.5.3 Wilson’s Disease Diagnostic Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Wilson’s Disease Diagnostic Market Size by Region
4.1.1 Global Wilson’s Disease Diagnostic Sales Quantity by Region (2018-2029)
4.1.2 Global Wilson’s Disease Diagnostic Consumption Value by Region (2018-2029)
4.1.3 Global Wilson’s Disease Diagnostic Average Price by Region (2018-2029)
4.2 North America Wilson’s Disease Diagnostic Consumption Value (2018-2029)
4.3 Europe Wilson’s Disease Diagnostic Consumption Value (2018-2029)
4.4 Asia-Pacific Wilson’s Disease Diagnostic Consumption Value (2018-2029)
4.5 South America Wilson’s Disease Diagnostic Consumption Value (2018-2029)
4.6 Middle East and Africa Wilson’s Disease Diagnostic Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2029)
5.2 Global Wilson’s Disease Diagnostic Consumption Value by Type (2018-2029)
5.3 Global Wilson’s Disease Diagnostic Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2029)
6.2 Global Wilson’s Disease Diagnostic Consumption Value by Application (2018-2029)
6.3 Global Wilson’s Disease Diagnostic Average Price by Application (2018-2029)
7 North America
7.1 North America Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2029)
7.2 North America Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2029)
7.3 North America Wilson’s Disease Diagnostic Market Size by Country
7.3.1 North America Wilson’s Disease Diagnostic Sales Quantity by Country (2018-2029)
7.3.2 North America Wilson’s Disease Diagnostic Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2029)
8.2 Europe Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2029)
8.3 Europe Wilson’s Disease Diagnostic Market Size by Country
8.3.1 Europe Wilson’s Disease Diagnostic Sales Quantity by Country (2018-2029)
8.3.2 Europe Wilson’s Disease Diagnostic Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Wilson’s Disease Diagnostic Market Size by Region
9.3.1 Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Wilson’s Disease Diagnostic Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2029)
10.2 South America Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2029)
10.3 South America Wilson’s Disease Diagnostic Market Size by Country
10.3.1 South America Wilson’s Disease Diagnostic Sales Quantity by Country (2018-2029)
10.3.2 South America Wilson’s Disease Diagnostic Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Wilson’s Disease Diagnostic Market Size by Country
11.3.1 Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Wilson’s Disease Diagnostic Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Wilson’s Disease Diagnostic Market Drivers
12.2 Wilson’s Disease Diagnostic Market Restraints
12.3 Wilson’s Disease Diagnostic Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Wilson’s Disease Diagnostic and Key Manufacturers
13.2 Manufacturing Costs Percentage of Wilson’s Disease Diagnostic
13.3 Wilson’s Disease Diagnostic Production Process
13.4 Wilson’s Disease Diagnostic Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Wilson’s Disease Diagnostic Typical Distributors
14.3 Wilson’s Disease Diagnostic Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Wilson’s Disease Diagnostic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Wilson’s Disease Diagnostic Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Orphalan Basic Information, Manufacturing Base and Competitors
Table 4. Orphalan Major Business
Table 5. Orphalan Wilson’s Disease Diagnostic Product and Services
Table 6. Orphalan Wilson’s Disease Diagnostic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Orphalan Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Wilson’s Disease Diagnostic Product and Services
Table 11. AstraZeneca Wilson’s Disease Diagnostic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Vivet Therapeutics Basic Information, Manufacturing Base and Competitors
Table 14. Vivet Therapeutics Major Business
Table 15. Vivet Therapeutics Wilson’s Disease Diagnostic Product and Services
Table 16. Vivet Therapeutics Wilson’s Disease Diagnostic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Vivet Therapeutics Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Wilson’s Disease Diagnostic Product and Services
Table 21. Pfizer Wilson’s Disease Diagnostic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. Ultragenyx Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Ultragenyx Pharmaceutical Major Business
Table 25. Ultragenyx Pharmaceutical Wilson’s Disease Diagnostic Product and Services
Table 26. Ultragenyx Pharmaceutical Wilson’s Disease Diagnostic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Ultragenyx Pharmaceutical Recent Developments/Updates
Table 28. Valeant Pharmaceuticals International, Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Valeant Pharmaceuticals International, Inc. Major Business
Table 30. Valeant Pharmaceuticals International, Inc. Wilson’s Disease Diagnostic Product and Services
Table 31. Valeant Pharmaceuticals International, Inc. Wilson’s Disease Diagnostic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Valeant Pharmaceuticals International, Inc. Recent Developments/Updates
Table 33. Noblepharma Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Noblepharma Co., Ltd. Major Business
Table 35. Noblepharma Co., Ltd. Wilson’s Disease Diagnostic Product and Services
Table 36. Noblepharma Co., Ltd. Wilson’s Disease Diagnostic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Noblepharma Co., Ltd. Recent Developments/Updates
Table 38. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Merck & Co., Inc. Major Business
Table 40. Merck & Co., Inc. Wilson’s Disease Diagnostic Product and Services
Table 41. Merck & Co., Inc. Wilson’s Disease Diagnostic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Merck & Co., Inc. Recent Developments/Updates
Table 43. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceuticals Major Business
Table 45. Teva Pharmaceuticals Wilson’s Disease Diagnostic Product and Services
Table 46. Teva Pharmaceuticals Wilson’s Disease Diagnostic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Teva Pharmaceuticals Recent Developments/Updates
Table 48. Wilson Therapeutics AB Basic Information, Manufacturing Base and Competitors
Table 49. Wilson Therapeutics AB Major Business
Table 50. Wilson Therapeutics AB Wilson’s Disease Diagnostic Product and Services
Table 51. Wilson Therapeutics AB Wilson’s Disease Diagnostic Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wilson Therapeutics AB Recent Developments/Updates
Table 53. Global Wilson’s Disease Diagnostic Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Wilson’s Disease Diagnostic Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Wilson’s Disease Diagnostic Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Wilson’s Disease Diagnostic, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Wilson’s Disease Diagnostic Production Site of Key Manufacturer
Table 58. Wilson’s Disease Diagnostic Market: Company Product Type Footprint
Table 59. Wilson’s Disease Diagnostic Market: Company Product Application Footprint
Table 60. Wilson’s Disease Diagnostic New Market Entrants and Barriers to Market Entry
Table 61. Wilson’s Disease Diagnostic Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Wilson’s Disease Diagnostic Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Wilson’s Disease Diagnostic Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Wilson’s Disease Diagnostic Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Wilson’s Disease Diagnostic Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Wilson’s Disease Diagnostic Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Wilson’s Disease Diagnostic Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Wilson’s Disease Diagnostic Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Wilson’s Disease Diagnostic Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Wilson’s Disease Diagnostic Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Wilson’s Disease Diagnostic Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Wilson’s Disease Diagnostic Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Wilson’s Disease Diagnostic Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Wilson’s Disease Diagnostic Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Wilson’s Disease Diagnostic Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Wilson’s Disease Diagnostic Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Wilson’s Disease Diagnostic Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Wilson’s Disease Diagnostic Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Wilson’s Disease Diagnostic Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Wilson’s Disease Diagnostic Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Wilson’s Disease Diagnostic Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Wilson’s Disease Diagnostic Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Wilson’s Disease Diagnostic Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Wilson’s Disease Diagnostic Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Wilson’s Disease Diagnostic Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Wilson’s Disease Diagnostic Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Wilson’s Disease Diagnostic Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Wilson’s Disease Diagnostic Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Wilson’s Disease Diagnostic Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Wilson’s Disease Diagnostic Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Wilson’s Disease Diagnostic Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Wilson’s Disease Diagnostic Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Wilson’s Disease Diagnostic Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Wilson’s Disease Diagnostic Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Wilson’s Disease Diagnostic Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Wilson’s Disease Diagnostic Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Wilson’s Disease Diagnostic Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Wilson’s Disease Diagnostic Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Wilson’s Disease Diagnostic Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Wilson’s Disease Diagnostic Raw Material
Table 121. Key Manufacturers of Wilson’s Disease Diagnostic Raw Materials
Table 122. Wilson’s Disease Diagnostic Typical Distributors
Table 123. Wilson’s Disease Diagnostic Typical Customers
List of Figures
Figure 1. Wilson’s Disease Diagnostic Picture
Figure 2. Global Wilson’s Disease Diagnostic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Wilson’s Disease Diagnostic Consumption Value Market Share by Type in 2022
Figure 4. Penicillamine Examples
Figure 5. Trientine Examples
Figure 6. Tetrathiomolybdate Examples
Figure 7. Global Wilson’s Disease Diagnostic Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Wilson’s Disease Diagnostic Consumption Value Market Share by Application in 2022
Figure 9. Hospital Pharmacies Examples
Figure 10. Online Pharmacies Examples
Figure 11. Retail Pharmacies Examples
Figure 12. Global Wilson’s Disease Diagnostic Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Wilson’s Disease Diagnostic Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Wilson’s Disease Diagnostic Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Wilson’s Disease Diagnostic Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Wilson’s Disease Diagnostic Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Wilson’s Disease Diagnostic Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Wilson’s Disease Diagnostic by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Wilson’s Disease Diagnostic Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Wilson’s Disease Diagnostic Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Wilson’s Disease Diagnostic Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Wilson’s Disease Diagnostic Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Wilson’s Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Wilson’s Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Wilson’s Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Wilson’s Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Wilson’s Disease Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Wilson’s Disease Diagnostic Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Wilson’s Disease Diagnostic Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Wilson’s Disease Diagnostic Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Wilson’s Disease Diagnostic Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Wilson’s Disease Diagnostic Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Wilson’s Disease Diagnostic Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Wilson’s Disease Diagnostic Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Wilson’s Disease Diagnostic Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Wilson’s Disease Diagnostic Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Wilson’s Disease Diagnostic Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Wilson’s Disease Diagnostic Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Wilson’s Disease Diagnostic Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Wilson’s Disease Diagnostic Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Wilson’s Disease Diagnostic Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Wilson’s Disease Diagnostic Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Wilson’s Disease Diagnostic Consumption Value Market Share by Region (2018-2029)
Figure 54. China Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Wilson’s Disease Diagnostic Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Wilson’s Disease Diagnostic Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Wilson’s Disease Diagnostic Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Wilson’s Disease Diagnostic Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Wilson’s Disease Diagnostic Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Wilson’s Disease Diagnostic Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Wilson’s Disease Diagnostic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Wilson’s Disease Diagnostic Market Drivers
Figure 75. Wilson’s Disease Diagnostic Market Restraints
Figure 76. Wilson’s Disease Diagnostic Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Wilson’s Disease Diagnostic in 2022
Figure 79. Manufacturing Process Analysis of Wilson’s Disease Diagnostic
Figure 80. Wilson’s Disease Diagnostic Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source